facebook
TradedTraded
    Home
    Deals
    Newsletter
    Articles
    PropTech
    Partners


Messages

Go Pro
+ Submit+ Submit
All Deals
November 20, 2025 - Deals

Emm Raises $9 Million Seed Funding Led By Lunar Ventures For Menstrual Care Technology

Property Image
Emm, led by CEO Jenny Button, has raised over $9M in Seed funding to advance its menstrual care technology. The round was led by Lunar Ventures, with participation from the Labcorp Venture Fund, Tiny VC, BlueLion Global, Alumni Ventures, and notable angels including Amar Shah, Vivek Garipalli, and Harpreet Rai. Emm combines sensor technology with medical-grade silicone to measure menstrual flow and track key cycle metrics, providing users with health insights while prioritizing privacy. The company plans a UK consumer launch in early 2026, with other markets to follow, and has opened its subscriber waitlist. FOUNDER: Jenny Button INVESTORS: Lunar Ventures, Labcorp Venture Fund, Tiny VC, BlueLion Global, Alumni Ventures, Amar Shah, Vivek Garipalli & Harpreet Rai ROUND: Seed AMOUNT: $9,000,000 HQ: #London #UnitedKingdom #VentureCapital #Emm #JennyButton #LunarVentures #LabcorpVentureFund #TinyVC #BlueLionGlobal #AlumniVentures #AmarShah #VivekGaripalli #HarpreetRai #TradedVC

Property Image
Colossal Biosciences In Talks For Funding Round Targeting $23 Billion ValuationColossal Biosciences, the de-extinction biotech startup known for its efforts to recreate the woolly mammoth and other extinct species, is reportedly in talks to raise new funding at a valuation of roughly $23 billion–$24 billion, according to Axios. The potential raise would mark a significant jump for the five-year-old company, with investors valuing not only its genetic-engineering programs but also its broader genomics, reproductive technology, conservation, and intellectual property platform. Colossal has begun generating revenue through conservation technology sales and technology spinouts, including Astromech, an AI-driven predictive modeling company, and Form Bio, a computational biology platform, expanding its value beyond de-extinction efforts. FOUNDERS: Ben Lamm & George Church TARGET VALUATION: $23,000,000,000 HQ: Dallas, Texas #VentureCapital #ColossalBiosciences #BenLamm #GeorgeChurch #TradedVC